ArticleThe Korean journal of internal medicine2018

Atorvastatin inhibits osteoclast differentiation by suppressing NF-κB and MAPK signaling during IL-1β-induced osteoclastogenesis.

Won-Seok Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.